Articles tagged with Respiratory Disorders
A study by Queen Mary University of London found that 26% of patients with asthma are overusing rescue inhalers, which can lead to poor asthma control and increased risk of severe attacks. By reducing SABA overprescribing, hospitals can see a 70% decrease in asthma-related hospital admissions.
A study using PET/CT revealed that residual COVID-19 symptoms can be attributed to ongoing lung inflammation. Treatment with steroids and antifibrotic drugs significantly decreased inflammatory activity.
Researchers used bacteriophage therapy to treat 20 complex, antibiotic-resistant lung infections in a clinical trial, resulting in no adverse reactions. More than half of treated patients experienced symptom improvement or reduced bacterial presence. The study's findings advance the promise of phage therapy as an alternative to traditi...
Researchers at Cedars-Sinai have discovered that zinc, a common mineral, plays an important role in reversing lung damage and improving survival for patients with idiopathic pulmonary fibrosis (IPF). By identifying a molecular pathway involving zinc, the team hopes to develop new therapies to reverse IPF-related lung damage.
A University of Washington-led team found that people in China with higher socioeconomic status are more exposed to outdoor air pollution. The study discovered a unique correlation between socioeconomic status and ambient air pollution levels, which runs counter to existing studies conducted in the US.
A secondary analysis of the MOVe-OUT trial found molnupiravir-treated participants had a decreased need for respiratory interventions and fewer COVID-19-related acute care visits. Additionally, they showed faster normalization of biomarkers and were discharged earlier than placebo-treated patients.
Researchers analyzed 140 complete autopsies of COVID-19 patients and found the most frequent profile is men aged 60-77 with acute lung injury, often accompanied by vascular disease, heart disease, and diabetes. This profile was associated with a shorter time to death.
A study found that COVID-19 disrupted RSV's seasonal pattern, leading to a 'collapse' of existing strains and emergence of new ones. The pandemic also accelerated the spread and evolution of other viruses like influenza.
A recent study published in Pharmaceutics suggests that berberine can suppress the proliferation of lung cancer cells, reduce airway inflammation, and modulate genes involved in inflammation. The researchers used liquid crystalline nanoparticles to enhance safety and effectiveness.
A study by Brazilian scientists reveals that autophagy can modulate the accumulation of mutant mitochondrial DNA in cells during aging. The researchers found that mice with liver-specific atg7 knockout showed reduced buildup of mutant DNA, suggesting a potential therapeutic target for diseases associated with mitochondrial DNA mutations.
A recent study reveals that 91% of athletes display dysfunctional breathing patterns, which can lead to increased risk of musculoskeletal injuries. The study emphasizes the importance of screening and addressing these patterns through targeted interventions and breathing training protocols.
A new study found that vaccinated people with mild breakthrough COVID-19 infections can experience debilitating long COVID symptoms. Vaccination reduced the risk of death by 34% and long COVID by 15%, but not all manifestations were prevented. Researchers emphasize the need for additional layers of protection to mitigate risks.
The Mount Sinai Hospital will recruit eight postdoctoral trainees for a five-year fellowship program in emergency care research. The program aims to investigate complex medical questions and lead to studies transforming patient care.
Researchers have discovered that short-chain fatty acid acetate from the gut microbiota can minimize the effects of infection by respiratory syncytial virus (RSV) and mitigate its severity. The compound was found to activate antiviral molecules, such as RIG-I, which are effective against RSV, leading to a 88% reduction in viral load.
A study published at ATS 2022 found that imatinib reduced mortality rates by 28.9% and shortened ICU stays among critically ill COVID-19 patients. The drug also improved ventilation outcomes and reduced the need for supplemental oxygen.
A multicenter trial found that brensocatib did not reduce clinical deterioration or mortality in severe COVID-19 patients. However, a sub-study revealed an anti-inflammatory effect of DPP1 inhibition on neutrophil protease enzymes, which may be beneficial for treating bronchiectasis.
According to a study published at the ATS 2022 international conference, nearly half of patients with abnormal findings in lung cancer screening experienced delays in following up. The median delay time was 91 days, with current smokers having longer delays than former smokers.
Research published at ATS 2022 found that historically redlined neighborhoods in California have higher COVID-19 case and death rates, with incidence rates 3.34 times higher than non-redlined areas
The substudy of the ADVOCATE trial found avacopan reduced glucocorticoid use by 86% in ANCA-associated vasculitis patients with respiratory and ENT involvement, while also showing superiority in remission compared to prednisone.
Researchers at UC San Diego School of Medicine found that COVID-19, MIS-C and Kawasaki disease share similar underlying molecular patterns. The study reveals that MIS-C is a more severe version of the immune response than KD, with potential implications for improved disease diagnosis and treatment.
A study found that significant racial disparities in emphysema prevalence occur predominantly among Black adults, even after adjusting for socioeconomic status and smoking. Traditional measures of lung health using race-specific norms may be under-recognizing impaired respiratory health in Black individuals.
Researchers discovered that e-cigarette vendors are adding synthetic cooling agents WS-3 and WS-23 to their products, which can cause organ toxicity. The study found that these agents were present in most popular e-cigarette brands, including Puffbar, and posed a risk to users, particularly when consumed regularly.
A study of over 8 million adults in England found significant increases in neuropsychiatric illnesses after hospitalization for COVID-19 or other severe acute respiratory infections. Risks were similar for both conditions.
The US Preventive Services Task Force (USPSTF) recommends against routine screening for chronic obstructive pulmonary disease (COPD) in asymptomatic adults who do not recognize or report respiratory symptoms. This decision is based on a lack of evidence showing the benefit of screening in preventing future cardiovascular events.
Researchers at San Diego State University have identified rare genetic markers in M. tuberculosis that could improve early detection of drug-resistant strains of the disease, helping prevent their spread. These markers may help block common TB drugs from interfering with the pathogen's ability to synthesize proteins.
Researchers at UC San Diego describe the underlying signaling pathway that causes PAH and a novel monoclonal antibody therapy that blocks abnormal blood vessel formation. The study reveals two opposing roles of NOTCH ligands and opens a door to a potentially new treatment for PAH.
A new study has found that adults with asthma are more likely to become obese later in life. The research, which included over 8,700 participants from 11 European countries and Australia, revealed that non-allergic asthma, longer disease duration, and corticosteroid treatment were associated with increased obesity risk.
A UCLA-led team found that an abnormally suppressed immune system, not a persistently hyperactive one, may be to blame for some cases of long COVID-19. The study suggests boosting immunity in those individuals could be a treatment option.
Researchers investigated Omicron's impact on children's upper airway infections and found a significant increase. The study suggests that as Omicron became the dominant SARS-CoV-2 variant, cases of upper airway infection among children rose sharply.
A new study has found higher levels of silica dust in the lung tissue of contemporary coal miners compared to previous generations, providing a rationale for the Mine Safety and Health Administration to develop a more protective occupational standard for silica. The study suggests that changing mining practices, which generated more si...
A new study published in the Chinese Medical Journal assessed mortality risk in middle-aged and older Chinese individuals with multiple diseases. The study identified four multimorbidity patterns, with cardiometabolic being the most common, and found that individuals with these patterns had a significantly increased mortality risk.
A new study has found a clear link between silica exposure and severe black lung disease in contemporary coal miners. The researchers attributed the resurgence of progressive massive fibrosis to changes in mining technology, such as mechanized coal extraction devices introduced in the 1950s.
The ATS 2022 International Conference features extensive programming on the latest advances in pulmonary, critical care, and sleep medicine. The conference will also provide access to on-demand recordings of sessions.
A recent study published in mBio discovered that the SARS-CoV-2 viral gene ORF8 plays a crucial role in the severity and spread of COVID-19. Researchers found that mutations in ORF8 contribute to inflammation and disease outcomes, suggesting new treatment options for patients with severe cases.
A team of researchers from Osaka University successfully established a mouse model that can reproduce the severe and persistent cough of pertussis. They found that pertussis toxin, Vag8, and lipooligosaccharide are key bacterial factors involved in inducing coughing, which ultimately leads to bradykinin and TRPV1 signaling.
Researchers have discovered a novel nano-therapy that prevents bronchopulmonary dysplasia (BPD) in premature babies. The therapy uses tiny particles released by mesenchymal stromal cells, which travel to the brain and lungs, reducing damage and improving lung and brain health.
A University of Gothenburg study found that IgA antibodies present in the respiratory tract protected healthcare workers from contracting COVID-19. The research, published in the European Journal of Immunology, suggests that these antibodies may play a crucial role in preventing severe illness and hospitalization.
Researchers develop novel therapeutic approach for treating tuberculosis using phosphatase inhibitors, offering potential benefits for TB research and basic biology exploration. The discovery provides a promising alternative to traditional antibiotic-based treatments and has significant implications for combating antimicrobial resistance.
A study found that higher doses of antibiotics are needed to eliminate bacterial infections with other microbes present. Researchers developed a model of the human airways to replicate poly-microbial infections, which often persist despite treatment in people with cystic fibrosis and other lung diseases.
A study of over 3,000 mother-child pairs from six European countries found an association between prenatal bisphenol A exposure and increased risk of asthma and wheezing in school-age girls. The study revealed a high prevalence of BPA in maternal urine during pregnancy.
A UC San Diego study found that excessive neuropeptide secretion by neuroendocrine cells in the lungs can lead to fluid buildup and poor oxygenation in both infant lung disease and COVID-19. Blocking these neuropeptides may be an effective treatment for conditions marked by excess lung fluid.
A clinical trial conducted by RCSI researchers found that administering alpha-1 antitrypsin to critically ill COVID-19 patients reduced inflammation after one week. The study's results are promising and may form the basis for a larger trial.
Scientists developed a powerful new tool called Giraffe to improve genomic research by leveraging global genetic diversity. The tool allows for the use of a diverse pangenome reference point, enabling faster and more sensitive comparisons of short-read human genome sequences.
A real-time electronic decision support system helped reduce intensive care unit admissions, improve antibiotic use, and lower overall mortality rates for patients with pneumonia. The study found a 38% decrease in mortality among community hospital patients using the system.
Researchers found that four-month treatment is as effective as six months in non-severe TB cases, allowing for savings on screening and training healthcare workers. The study's results led to a change in the World Health Organisation's global guidelines, recommending a shorter treatment course for children with non-severe TB.
Researchers at KTH Royal Institute of Technology developed a technique to study lung disease in living mice without using mechanical ventilation. The method uses phase-contrast X-ray tomography to produce high-resolution images of the lungs, including even the smallest airways, with low radiation doses.
A landmark study published in JAMA reveals that hurricanes and tropical cyclones in the US are associated with increased deaths from various causes, including injuries, infectious diseases, and cardiovascular conditions. The study analyzed 33.6 million death records and found a significant increase in mortality rates after tropical cyc...
The American Thoracic Society and European Respiratory Society have updated their technical standard for pulmonary function tests to address interpretation uncertainty and health inequity concerns. The new guidelines emphasize the importance of considering an individual's medical history, symptoms, and social circumstances when applyin...
A new study found that e-cigarette vapers and hookah smokers are more likely to exhale particles through their nose compared to cigarette smokers. This unique breathing pattern may expose the nose and sinuses to higher levels of emissions, increasing the risk of upper respiratory diseases.
A new study reveals that face masks can play a crucial role in reducing the risk of Covid-19 transmission, with risks decreasing by up to 99% when worn correctly. The researchers developed a more advanced model to assess viral exposure risks and found that even short distances become negligible with proper mask-wearing.
The study reveals that asbestos minerals undergo changes that resemble self-defense when internalized by human lung cells. These changes include the formation of an iron-rich layer on the minerals, which may be a mechanism to protect the cell from toxicity.
The ATS 2022 International Conference will take place in San Francisco from May 15-18, featuring a gathering of scientists and clinicians in pulmonary, critical care, and sleep medicine. The conference will showcase accelerated research and clinical applications across lung diseases, including COVID-19.
Researchers aim to eliminate respirable coal mine dust toxicity with chemical additives, targeting ultrafine particles and quartz. The project will investigate particle surface chemistry and aging effects on toxicity, with potential applications in metal, non-metal mining, and construction.
A new study suggests that incomplete lung cell repair may contribute to the development of chronic fibrotic lung disease in COVID-19 and non-COVID patients. The research proposes novel therapies to promote healthy regeneration and prevent scarring.
Research suggests a possible silver lining for great ape conservation: a decline in respiratory illnesses among wild mountain gorillas in Rwanda since the COVID-19 pandemic began. The reduced number of outbreaks correlates with decreased human-gorilla proximity and additional health measures.
Pulmonary lymphangioleiomyomatosis (LAM) is a rare cancer affecting up to 1 in 1 million women worldwide, characterized by uncontrolled tumor cell growth. Researchers aim to identify new therapeutic targets using extracellular vesicles, with the goal of developing new therapies for LAM patients.
Researchers found that higher monocyte counts are linked to early signs of injury and scarring on lung imaging among community-dwelling adults. This suggests that hyperactive monocytes may contribute to lung injury at the early stages of interstitial lung disease.
Scientists at UC Riverside and UCLA have engineered nanoparticles to serve as 'molecular traps' that bind to SARS-CoV-2, preventing it from attacking macrophages and inducing inflammation. The findings suggest potential therapeutic strategies for treating COVID-19-associated diseases.
A cross-disciplinary team identified a previously unknown genetic cause of interstitial lung disease in a 2-year-old child, revealing a variant in the RAB5B gene that causes surfactant dysfunction. The discovery may lead to finding answers for other patients with similar conditions.
A new study found that patients with chronic non-communicable diseases are more than twice as likely to die from any cause if they also have a psychiatric comorbidity. Comorbid psychiatric disorders were associated with higher all-cause mortality rates, ranging from 5.5-21.1%.